Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

438 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing severe asthma.
Robinson DS. Robinson DS. Eur Respir J. 2016 Sep;48(3):611-3. doi: 10.1183/13993003.01034-2016. Eur Respir J. 2016. PMID: 27581403 Free article. No abstract available.
Systematic assessment of difficult-to-treat asthma.
Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF; Asthma and Allergy Research Group of the National Heart and Lung Institute. Robinson DS, et al. Eur Respir J. 2003 Sep;22(3):478-83. doi: 10.1183/09031936.03.00017003. Eur Respir J. 2003. PMID: 14516138 Free article.
Cost advantages of combination asthma therapy.
Campbell DA, Robinson DS. Campbell DA, et al. Among authors: robinson ds. Treat Respir Med. 2004;3(3):133-7. doi: 10.2165/00151829-200403030-00001. Treat Respir Med. 2004. PMID: 15219172
How is difficult asthma managed?
Roberts NJ, Robinson DS, Partridge MR. Roberts NJ, et al. Among authors: robinson ds. Eur Respir J. 2006 Nov;28(5):968-73. doi: 10.1183/09031936.06.00003706. Epub 2006 Jun 28. Eur Respir J. 2006. PMID: 16807267 Free article.
Frequent exacerbators--a distinct phenotype of severe asthma.
Kupczyk M, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, Nizankowska-Mogilnicka E, Gjomarkaj M, Gaga M, Brusselle G, Dahlén B, Dahlén SE; BIOAIR investigators. Kupczyk M, et al. Clin Exp Allergy. 2014 Feb;44(2):212-21. doi: 10.1111/cea.12179. Clin Exp Allergy. 2014. PMID: 24447083 Free article. Clinical Trial.
Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes.
Samitas K, Poulos N, Semitekolou M, Morianos I, Tousa S, Economidou E, Robinson DS, Kariyawasam HH, Zervas E, Corrigan CJ, Ying S, Xanthou G, Gaga M. Samitas K, et al. Among authors: robinson ds. Eur Respir J. 2016 Mar;47(3):769-82. doi: 10.1183/13993003.00437-2015. Epub 2016 Feb 11. Eur Respir J. 2016. PMID: 26869672 Free article.
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Mansur AH, Fowler SJ, Niven RM, Howarth PH, Lordan JL, Menzies-Gow A, Harrison TW, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID; investigators for the MRC Refractory Asthma Stratification Programme. Heaney LG, et al. Among authors: robinson ds. Lancet Respir Med. 2021 Jan;9(1):57-68. doi: 10.1016/S2213-2600(20)30397-0. Epub 2020 Sep 8. Lancet Respir Med. 2021. PMID: 32916135 Free PMC article. Clinical Trial.
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
Busby J, Matthews JG, Chaudhuri R, Pavord ID, Hardman TC, Arron JR, Bradding P, Brightling CE, Choy DF, Cowan DC, Djukanovic R, Hanratty CE, Harrison TW, Holweg CT, Howarth PH, Fowler SJ, Lordan JL, Mansur AH, Menzies-Gow A, Niven RM, Robinson DS, Walker SM, Woodcock A, Heaney LG; investigators for the MRC Refractory Asthma Stratification Programme. Busby J, et al. Among authors: robinson ds. Eur Respir J. 2021 Sep 24;59(4):2100768. doi: 10.1183/13993003.00768-2021. Print 2022 Apr. Eur Respir J. 2021. PMID: 34561291 Free PMC article. Clinical Trial.
438 results